Entero Healthcare Solutions

India Urbanization And Market Consolidation Will Expand Pharma Distribution

AnalystConsensusTarget

Not Invested

Consensus Narrative from 4 Analysts

Published

05 Sep 25

AnalystConsensusTarget's Fair Value

₹1,497.00

21.1% undervalued

05 Sep

₹1,181.30

-14.9%

-2.3%

-14.9%

-2.3%

Edit anytime before Sep 5 8:13 PM. Then post Updates to your followers.

Author's Valuation

₹1.5k

21.1% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

₹1.5k

21.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

19.71%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.73%

Calculation

₹3.01b

Earnings '28

30.65x

PE Ratio '28

₹92.21b

Market Cap '28

₹92.21b

Market Cap '28

43.55m

No. shares '28

₹2.12k

Share Price '28

₹2.12k Share Price '28

Discounted to 2025 @ 12.73% p.a.

₹1.48k

Fair Value '25